Skip to content
Open access

A neonatal S100A8+ macrophage subset orchestrates inflammation resolution and cardiac regeneration after myocardial infarction

Oct 2026 · European Heart Journal · 0 citations

Abstract

Myocardial infarction (MI) remains a leading cause of heart failure due to the adult mammalian heart's limited regenerative capacity, which precludes the restoration of lost myocardium. In contrast, neonatal mice retain a transient ability to regenerate after injury within the first seven days of life (P7). During this regenerative process, macrophages have been shown to play a pivotal role in cardiac regeneration. The underlying cellular and molecular mechanisms, however, remain poorly understood. Using single-cell RNA sequencing of cardiac macrophages isolated from neonatal and adult mouse hearts ten days post-MI, we identified a neonatal-enriched population with granulocyte-like transcriptional features and high S100A8 expression (S100A8⁺ macrophages). Flow cytometry confirmed a marked expansion of these cells during the subacute phase in neonatal hearts, coinciding with accelerated neutrophil clearance, whereas adult hearts exhibited persistent neutrophil accumulation and inflammation. Genetic ablation of S100A8⁺ macrophages in MRP8-Cre-iDTR mice impaired post-MI cardiac regeneration, as evidenced by reduced cardiomyocyte proliferation, exacerbated inflammation and fibrosis, confirming their essential role in neonatal cardiac repair and regeneration. Ligand-receptor analyses demonstrated that S100A8⁺ macrophages promote cardiomyocyte proliferation and angiogenesis through NRG1–ErbB4 and VEGFA-associated signaling, respectively. Furthermore, in vitro and in vivo assays confirmed that S100A8⁺ macrophages drive neutrophil apoptosis, a process likely mediated by THBS1–CD47 and ANXA1–FPR2 interactions, as specific enrichment of Thbs1 and Anxa1 in this subset was confirmed by independent RNA-Seq. Importantly, re-analysis of historic human cardiac datasets confirmed the infiltration of S100A8⁺ macrophages in the human failing heart, suggesting evolutionary conservation of this subset and highlighting its potential role in myocardial repair. Our findings identify S100A8⁺ macrophages as a functionally specialized subset that orchestrates inflammation resolution, cardiomyocyte proliferation, and angiogenesis during neonatal cardiac regeneration, likely through paracrine signaling. Targeting S100A8⁺ macrophage subset and the signaling pathways it engages, therefore, represents a promising therapeutic strategy to enhance myocardial repair and functional recovery following MI.Graphical abstract

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.